Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M788Revenue (TTM) $M--Net Margin (%)--Altman Z-Score3.6
Enterprise Value $M622EPS (TTM) $-2.3Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.9Pre-tax Margin (%)--Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %--Quick Ratio8.8Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %20.4Current Ratio8.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-42.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-49.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M61.9ROIC % (ttm)-257.8Gross Margin Increase y-yN

Gurus Latest Trades with INSM

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INSMJohn Paulson 2016-03-31 Add$11.35 - $18.15
($13.24)
$ 12.74-4%Add 24.21%205,200
INSMJohn Paulson 2015-12-31 Buy 0.02%$15.84 - $20.7
($17.6)
$ 12.74-28%New holding165,200
INSMLeon Cooperman 2015-06-30 Sold Out -0.02%$20.04 - $25.07
($22.67)
$ 12.74-44%Sold Out0
INSMLeon Cooperman 2015-03-31 Buy 0.02%$14.16 - $22
($17.62)
$ 12.74-28%New holding75,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INSM is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


INSM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Drechsler Andrew TCFO 2016-11-14Sell45,000$14.67-13.16view
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs. 2016-11-09Sell68,774$11.956.61view
Lewis WilliamPresident & CEO 2016-02-01Buy50,000$13.34-4.5view
HAYDEN DONALD J JRDirector 2015-09-02Sell25,000$24.06-47.05view
Quigley MarkVice President, Quality 2015-05-12Sell18,750$22.07-42.27view
SHAROKY MELVIN MDDirector 2014-08-13Buy88,889$11.2513.24view
Lewis WilliamPresident and CEO 2013-11-01Buy5,233$14.28-10.78view
FMR LLCEdward C. Johnson 3d 2013-07-22Sell158,758$12.025.99view
FMR LLCEdward C. Johnson 3d 2013-07-18Sell310,227$11.4910.88view
FMR LLCEdward C. Johnson 3d 2013-07-15Sell161,531$10.7918.07view

Quarterly/Annual Reports about INSM:

News about INSM:

Articles On GuruFocus.com
Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
Weekly CEO Buys Highlight: TPGI, INSM, EQU, FCEL Jan 13 2013 
INSMED Inc -- A Merger Ruined its Net-Net Status Feb 02 2011 
Insmed Inc. Reports Operating Results (10-Q) Nov 03 2010 
Insmed Inc. Reports Operating Results (10-Q) Aug 04 2010 
Insmed Inc. Reports Operating Results (10-Q) May 06 2010 
Jim Simons Low P/E Stocks: Insmed Inc., Paragon Shipping Inc., The Student Loan Corp., Hellenic Tele Apr 28 2010 
8 Cheap Stocks Below Net Net Working Capital Dec 14 2009 
Insmed Inc. Reports Operating Results (10-Q) Nov 09 2009 
Insmed Inc. Q3 Net Net Stock Analysis and Valuation Nov 09 2009 

More From Other Websites
Hedge Funds Sour Slightly On Insmed Incorporated (INSM), But Remain Overweight Dec 05 2016
Insmed, Inc. :INSM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 Nov 28 2016
Insmed to Participate at November Investor Conferences Nov 14 2016
Insmed to Participate at November Investor Conferences Nov 14 2016
INSMED INC Financials Nov 09 2016
Robbins Arroyo LLP Is Investigating the Officers and Directors of Insmed, Inc. (INSM) on Behalf of... Nov 04 2016
Edited Transcript of INSM earnings conference call or presentation 3-Nov-16 12:30pm GMT Nov 04 2016
Insmed reports 3Q loss Nov 03 2016
Insmed reports 3Q loss Nov 03 2016
Insmed Reports Third Quarter 2016 Financial Results and Provides Business Update Nov 03 2016
INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or... Nov 03 2016
INSMED INC Files SEC form 10-Q, Quarterly Report Nov 03 2016
Insmed Reports Third Quarter 2016 Financial Results and Provides Business Update Nov 03 2016
Q3 2016 Insmed Inc Earnings Release - Before Market Open Nov 03 2016
Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016 Oct 27 2016
Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016 Oct 27 2016
Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous... Oct 18 2016
Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous... Oct 18 2016
AstraZeneca licenses respiratory drug to Insmed Oct 05 2016
AstraZeneca licenses respiratory drug to Insmed Oct 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)